2JP-13960-14165
4 vaccinations
7 coded responses
20 check-ins
7 free-text entries
7 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 498 / MI
- Registered
- 2021-01-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Dose 1 — Pfizer-BioNTech
-
2021-01-12
Dose 2 — Pfizer-BioNTech
-
2021-01-13
Registered in v-safe
-
2021-01-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Muscle or body achesAdult check-in
-
2021-01-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-16
- 2021-01-18
- 2021-01-19
- 2021-01-29
- 2021-02-04
- 2021-02-10
-
2021-02-18
Survey response — day 35, dose 2MedDRA: Adverse reaction — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: I am being work up for IgG4RD, and may be getting close to a diagnosis.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-18
Report sent to call center — day 35, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-02-25
Survey response — day 42, dose 2MedDRA: Fatigue, Lymphadenopathy mediastinal, Pulmonary mass — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: Fatigue, mediastinal lymphadenopathy, pulmonary masses.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-25
Report sent to call center — day 42, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-13
-
2021-07-13
Survey response — 6 months, dose 2MedDRA: Osteoarthritis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Right knee osteoarthritis.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-13
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-15
- 2021-07-31
-
2021-09-01
Dose 3 — Pfizer-BioNTech
-
2021-10-01
Survey response — day 28, dose 3MedDRA: Cerebrovascular accident, Ligament sprain — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Small stroke.Right knee strain.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-01
Report sent to call center — day 28, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2021-10-04
Call successfulDoes not wish to fill out VAERS report
- 2021-10-06
- 2021-10-13
-
2021-12-03
Survey response — 3 months, dose 3MedDRA: Muscle spasms — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Muscle spasms in left upper trapezius and rhomboid area.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-03
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-12-09
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-02-17
Dose 4 — Moderna
-
2022-03-02
Survey response — 6 months, dose 3MedDRA: Bursitis, Nasal congestion — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Nasal stuffiness, right olecranon bursitisMedDRA releases: 2024-11 · check-in free text available
-
2022-03-02
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-03-03
-
2022-03-04
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-05-19
Survey response — 3 months, dose 4MedDRA: Condition aggravated, Office visit, Pre-existing disease, Pulmonary mass — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: My IgG4 disease has provided me a new lung lesion. I am back on 40 mg of prednisone/ day and will have another CT in about 3 weeks to monitor the lesion. Am feeling better on the steroid. · Healthcare visit (other): Office visitMedDRA releases: 2024-11 · check-in free text available
-
2022-05-19
Report sent to call center — 3 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2022-05-20
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-08-19
- 2023-02-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | |
| 3 | 2021-09-01 | Pfizer-BioNTech | No |
| 4 | 2022-02-17 | Moderna | No |
Call center
7 call center cases
7 successful
Free text
Release 4 — day 35, dose 2
Symptoms: I am being work up for IgG4RD, and may be getting close to a diagnosis.
Release 4 — day 42, dose 2
Symptoms: Fatigue, mediastinal lymphadenopathy, pulmonary masses.
Release 9 — 6 months, dose 2
Symptoms: Right knee osteoarthritis.
Release 9 — day 28, dose 3
Symptoms: Small stroke.Right knee strain.
Release 10 — 3 months, dose 3
Symptoms: Muscle spasms in left upper trapezius and rhomboid area.
Release 11 — 6 months, dose 3
Symptoms: Nasal stuffiness, right olecranon bursitis
Release 11 — 3 months, dose 4
Symptoms: My IgG4 disease has provided me a new lung lesion. I am back on 40 mg of prednisone/ day and will have another CT in about 3 weeks to monitor the lesion. Am feeling better on the steroid.
Healthcare visit (other): Office visit
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Adverse reaction | ✓ | ✓ | ✓ |
| SD | Bursitis | · | · | ✓ |
| SD | Cerebrovascular accident | · | · | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Ligament sprain | · | · | ✓ |
| SD | Lymphadenopathy mediastinal | ✓ | ✓ | ✓ |
| SD | Muscle spasms | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Osteoarthritis | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pulmonary mass | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release